Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Stumblinbear@pawb.social
    link
    fedilink
    English
    arrow-up
    1
    arrow-down
    1
    ·
    1 year ago

    Eh, they have about as much power over that as they do any other privacy breaches. It being DNA doesn’t make a huge difference